- Home
- AKRO vs WLYB Comparison
AKRO vs WLYB Comparison
Compare AKRO & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- WLYB
- Stock Information
- Founded
- AKRO 2017
- WLYB 1807
- Country
- AKRO United States
- WLYB United States
- Employees
- AKRO N/A
- WLYB N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- WLYB Books
- Sector
- AKRO Health Care
- WLYB Consumer Discretionary
- Exchange
- AKRO Nasdaq
- WLYB Nasdaq
- Market Cap
- AKRO 2.8B
- WLYB 2.3B
- IPO Year
- AKRO 2019
- WLYB N/A
- Fundamental
- Price
- AKRO $39.85
- WLYB $44.00
- Analyst Decision
- AKRO Strong Buy
- WLYB
- Analyst Count
- AKRO 9
- WLYB 0
- Target Price
- AKRO $76.29
- WLYB N/A
- AVG Volume (30 Days)
- AKRO 1.1M
- WLYB 199.0
- Earning Date
- AKRO 05-16-2025
- WLYB 06-12-2025
- Dividend Yield
- AKRO N/A
- WLYB 3.21%
- EPS Growth
- AKRO N/A
- WLYB N/A
- EPS
- AKRO N/A
- WLYB 0.75
- Revenue
- AKRO N/A
- WLYB $1,703,491,000.00
- Revenue This Year
- AKRO N/A
- WLYB N/A
- Revenue Next Year
- AKRO N/A
- WLYB $1.13
- P/E Ratio
- AKRO N/A
- WLYB $58.26
- Revenue Growth
- AKRO N/A
- WLYB N/A
- 52 Week Low
- AKRO $17.86
- WLYB $35.68
- 52 Week High
- AKRO $58.40
- WLYB $52.90
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- WLYB 65.28
- Support Level
- AKRO $41.60
- WLYB $39.54
- Resistance Level
- AKRO $46.47
- WLYB $44.15
- Average True Range (ATR)
- AKRO 2.26
- WLYB 0.01
- MACD
- AKRO 0.08
- WLYB 0.11
- Stochastic Oscillator
- AKRO 21.84
- WLYB 86.96
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.